Nanexa Past Earnings Performance
Past criteria checks 0/6
Nanexa's earnings have been declining at an average annual rate of -36%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 40.2% per year.
Key information
-36.0%
Earnings growth rate
-0.8%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 40.2% |
| Return on equity | -79.7% |
| Net Margin | -129.1% |
| Next Earnings Update | 03 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Nanexa makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 59 | -76 | 48 | 0 |
| 30 Sep 23 | 52 | -43 | 48 | 0 |
| 30 Jun 23 | 47 | -49 | 48 | 0 |
| 31 Mar 23 | 35 | -55 | 47 | 0 |
| 31 Dec 22 | 27 | -59 | 52 | 0 |
| 30 Sep 22 | 24 | -54 | 46 | 0 |
| 30 Jun 22 | 19 | -50 | 42 | 0 |
| 31 Mar 22 | 18 | -42 | 39 | 0 |
| 31 Dec 21 | 18 | -36 | 33 | 0 |
| 30 Sep 21 | 19 | -31 | 36 | 0 |
| 30 Jun 21 | 22 | -27 | 31 | 0 |
| 31 Mar 21 | 22 | -25 | 24 | 0 |
| 31 Dec 20 | 21 | -22 | 22 | 0 |
| 30 Sep 20 | 18 | -19 | 11 | 0 |
| 30 Jun 20 | 13 | -18 | 10 | 0 |
| 31 Mar 20 | 11 | -13 | 9 | 0 |
| 31 Dec 19 | 9 | -13 | 8 | 0 |
| 30 Sep 19 | 7 | -12 | 9 | 0 |
| 30 Jun 19 | 6 | -11 | 8 | 0 |
| 31 Mar 19 | 4 | -12 | 8 | 0 |
| 31 Dec 18 | 4 | -11 | 8 | 0 |
| 30 Sep 18 | 4 | -9 | 7 | 0 |
| 30 Jun 18 | 4 | -9 | 6 | 0 |
| 31 Mar 18 | 4 | -8 | 6 | 0 |
| 31 Dec 17 | 3 | -8 | 6 | 0 |
| 30 Sep 17 | 3 | -8 | 6 | 0 |
| 30 Jun 17 | 2 | -8 | 5 | 0 |
| 31 Mar 17 | 2 | -7 | 5 | 0 |
| 31 Dec 16 | 2 | -6 | 5 | 0 |
| 30 Sep 16 | 2 | -6 | 4 | 0 |
| 30 Jun 16 | 2 | -6 | 4 | 0 |
| 31 Mar 16 | 2 | -5 | 4 | 0 |
| 31 Dec 15 | 2 | -4 | 4 | 0 |
| 30 Sep 15 | 1 | -2 | 2 | 0 |
| 30 Jun 15 | 0 | -2 | 1 | 0 |
| 31 Mar 15 | 0 | -1 | 0 | 0 |
| 31 Dec 14 | 0 | -1 | 0 | 0 |
| 30 Apr 14 | 1 | 0 | 2 | 0 |
Quality Earnings: NANEXA is currently unprofitable.
Growing Profit Margin: NANEXA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NANEXA is unprofitable, and losses have increased over the past 5 years at a rate of 36% per year.
Accelerating Growth: Unable to compare NANEXA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NANEXA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: NANEXA has a negative Return on Equity (-79.72%), as it is currently unprofitable.